SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-22-020341
Filing Date
2022-08-12
Accepted
2022-08-12 16:06:23
Documents
5
Effectiveness Date
2022-08-12
Reference 429
333-233381

Document Format Files

Seq Description Document Type Size
1 dffn20220811_s8.htm S-8 77222
2 ex_411823.htm EX-5.1 13908
3 ex_411584.htm EX-23.1 2248
4 ex_411585.htm EX-FILING FEES 35009
5 image01.jpg GRAPHIC 3993
  Complete submission text file 0001437749-22-020341.txt   135447
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266827 | Film No.: 221160073
SIC: 2834 Pharmaceutical Preparations